| Literature DB >> 14534431 |
Matthias Klugmann1, C Wymond Symes, Bettina K Klaussner, Claudia B Leichtlein, Tadao Serikawa, Deborah Young, Matthew J During.
Abstract
Aspartoacylase metabolizes N-acetylaspartic acid to produce L-aspartate and acetate. An aspartoacylase deficiency in humans is responsible for Canavan disease, a lethal autosomal recessive leukodystrophy. The role of aspartoacylase in the mammalian brain is unclear. Here we have generated and characterized a highly specific polyclonal antibody against aspartoacylase which recognizes a 37 kDa monomer and a dimer in normal but not in aspartoacylase-deficient rat tissue. Aspartoacylase protein expression sharply increases at P14, peaks at P28 and plateaus thereafter. Biochemical analysis reveals immunoreactivity in cytosolic but not in membrane fractions. Histologically, most abundant expression was observed in white matter tracts and thalamus. On the cellular level, aspartoacylase immunoreactivity is restricted to oligodendrocyte somata in both white and gray matter.Entities:
Mesh:
Substances:
Year: 2003 PMID: 14534431 DOI: 10.1097/00001756-200310060-00016
Source DB: PubMed Journal: Neuroreport ISSN: 0959-4965 Impact factor: 1.837